These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2884771)

  • 21. Combined effects of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
    Shimizu T; Iwamoto Y; Yanagihara Y; Ikeda K; Achiwa K
    Int J Immunopharmacol; 1992 Nov; 14(8):1415-20. PubMed ID: 1464473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sarcoma-derived protein regulates hepatocyte metabolism via autocrine production of tumor necrosis factor-alpha.
    Fischer CP; Bode BP; Souba WW
    Ann Surg; 1996 Oct; 224(4):476-83; discussion 483-5. PubMed ID: 8857852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ineffectiveness of poly rI:rC on transplanted tumors induced by methylcholanthrene.
    Meier H; Myers DD; Huebner RJ
    Naturwissenschaften; 1970 May; 57(5):248-9. PubMed ID: 5448325
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-tumoral and anti-inflammatory effects of biological stains.
    Culo F; Sabolović D; Somogyi L; Marusić M; Berbiguier N; Galey L
    Agents Actions; 1991 Nov; 34(3-4):424-8. PubMed ID: 1810151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor mechanism of intradermal administration of lipopolysaccharide.
    Inagawa H; Nishizawa T; Takagi K; Goto S; Soma G; Mizuno D
    Anticancer Res; 1997; 17(3C):1961-4. PubMed ID: 9216652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antitumor potency of polyethylene glycolylated tumor necrosis factor-alpha: a novel polymer-conjugation technique with a reversible amino-protective reagent.
    Tsunoda S; Ishikawa T; Yamamoto Y; Kamada H; Koizumi K; Matsui J; Tsutsumi Y; Hirano T; Mayumi T
    J Pharmacol Exp Ther; 1999 Jul; 290(1):368-72. PubMed ID: 10381801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity.
    Nakamura S; Kato A; Masegi T; Fukuoka M; Kitai K; Ogawa H; Ichikawa Y; Maeda M; Watanabe N; Kohgo Y
    Int J Cancer; 1991 Jul; 48(5):744-8. PubMed ID: 1649139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of vasoactive amines in the antitumor activity of endotoxin.
    Bloksma N; Kuper CF; Hofhuis FM; Willers JM
    Immunopharmacology; 1984 Jun; 7(3-4):201-9. PubMed ID: 6469605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosensitization of two murine fibrosarcomas with 6-thioguanine.
    Kim JH; Alfieri AA; Kim SH; Hong SS
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):583-6. PubMed ID: 2318691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
    Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
    Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin.
    Clauss M; Murray JC; Vianna M; de Waal R; Thurston G; Nawroth P; Gerlach H; Bach R; Familletti PC; Stern D
    J Biol Chem; 1990 Apr; 265(12):7078-83. PubMed ID: 2324115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
    Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemorrhagic tumour necrosis following endotoxin administration. I. Communication: morphological investigation on endotoxin-induced necrosis of the methylcholanthrene (Meth A) tumour in the mouse.
    Freudenberg N; Joh K; Westphal O; Mittermayer C; Freudenberg MA; Galanos C
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(4):377-89. PubMed ID: 6429940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid tumor regression caused by antitumor polysaccharide and induction of tumor-regressing factor in the serum of tumor-bearing mice.
    Kunimoto T; Baba H; Nitta K
    J Biol Response Mod; 1986 Apr; 5(2):160-7. PubMed ID: 3734842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature.
    Stoelcker B; Ruhland B; Hehlgans T; Bluethmann H; Luther T; Männel DN
    Am J Pathol; 2000 Apr; 156(4):1171-6. PubMed ID: 10751341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
    Winkelhake JL; Stampfl S; Zimmerman RJ
    Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the cytokine rhTNF-alpha on the population of mast cells in the growth of MethA fibrosarcoma--a TEM study.
    Terlikowski SJ; Nowak HF; Famulski W; Sulkowska M
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():199-200. PubMed ID: 11820606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity.
    Shimomura K; Manda T; Mukumoto S; Kobayashi K; Nakano K; Mori J
    Int J Cancer; 1988 Feb; 41(2):243-7. PubMed ID: 3338873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.